Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Psoriasis Linked with Inflammatory Bowel Disease

JAMA Dermatol; ePub 2018 Oct 24; Fu, Lee, et al

Psoriasis is significantly associated with inflammatory bowel disease (IBD), according to a recent study. Therefore, gastroenterology consultation may be indicated when patients with psoriasis present with bowel symptoms. For this systematic review and meta-analysis, literature was searched for relevant studies from inception to January 17, 2018. Case-control, cross-sectional, or cohort studies that examined either the odds or risk of IBD in patients with psoriasis were included. Researchers found:

  • A total of 5 case-control or cross-sectional studies and 4 cohort studies with 7,794,087 study participants were included.
  • Significant associations were found between psoriasis and Crohn’s disease (odds ratio, 1.70) and between psoriasis and ulcerative colitis (odds ratio, 1.75).
  • Patients with psoriasis had an increased risk of Crohn’s disease (risk ratio, 2.53) and ulcerative colitis (risk ratio, 1.71).
Citation:

Fu Y, Lee C-H, Chi C-C. Association of psoriasis with inflammatory bowel disease.

A systematic review and meta-analysis. [Published online ahead of print October 24, 2018]. JAMA Dermatol. doi:10.1001/jamadermatol.2018.3631.

This Week's Must Reads

Dermatomyositis, Negative ANA, and Malignancy Risk, J Am Acad Dermatol; ePub 2018 Nov 17; Hoesly, et al

Head/Neck Melanomas Have High Local Recurrence Risk, J Am Acad Dermatol; ePub 2018 Nov 17; Fix, et al

DOT Laser Offers Low Incidence of Adverse Effects, J Drugs Dermatol; 2018 Nov; Sarnoff, Gotkin, et al

Frontal Fibrosing Alopecia and Severity Factors , Dermatology (Karger); ePub 2018 Nov 22; Mervis, et al

Unsafe Neighborhoods Linked with Higher AD Risk, Ann Allergy Asthma Immunol; ePub 2018 Oct 26; McKenzie, et al

Must Reads in Psoriasis

Genetic Architecture of Psoriasis Explored , J Investig Dermatol Proc; 2018 Dec; Elder

Association Found Between HS and Psoriasis, J Am Acad Dermatol; ePub 2018 Nov 28; Kridin, et al

Ixekizumab Provides Rapid Improvement of Itch, Dermatolog Ther (Heidelb); ePub 2018 Dec; Yosipovitch, et al

Role of IL-17 in Psoriasis Pathogenesis Examined, Clin Rev Allerg Immunol; 2018 Dec; Blauvelt, et al

Ixekizumab: A Safe, Effective Psoriasis Treatment , J Cutan Med Surg; ePub 2018 Nov 18; Georgakopoulos, et al